carboxyamidotriazole
Term · Oncology and biomedicine · MLC-T-ONC-001422
An anticancer drug that belongs to the family of drugs called angiogenesis inhibitors.
An orally-active agent with potential antineoplastic activity. Carboxyamidotriazole binds to and inhibits non-voltage-operated Ca2+ channels, blocking both Ca2+ influx into cells and Ca2+ release from intracellular stores and resulting in the disruption of calcium channel-mediated signal transduction and inhibition of vascular endothelial growth factor (VEGF) signaling, endothelial proliferation, and angiogenesis. This agent may also inhibit tumor cell growth, invasion and metastasis.
| Identifier | MLC-T-ONC-001422 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | CAI |
| Synonyms | carboxyamido-triazole; carboxyaminoimidazole |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-001422",
"term": "carboxyamidotriazole",
"field": "Oncology and biomedicine",
"definitions": [
"An anticancer drug that belongs to the family of drugs called angiogenesis inhibitors.",
"An orally-active agent with potential antineoplastic activity. Carboxyamidotriazole binds to and inhibits non-voltage-operated Ca2+ channels, blocking both Ca2+ influx into cells and Ca2+ release from intracellular stores and resulting in the disruption of calcium channel-mediated signal transduction and inhibition of vascular endothelial growth factor (VEGF) signaling, endothelial proliferation, and angiogenesis. This agent may also inhibit tumor cell growth, invasion and metastasis."
],
"abbreviation": "CAI",
"synonyms": [
"carboxyamido-triazole",
"carboxyaminoimidazole"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/carboxyamidotriazole/"
}
Record 4,210 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.